Inspira Technologies, founded in 2018, is an innovative Medical Technology Company focused on the acute respiratory care market. The ART, Inspira’s novel technology, can address the unmet need of providing acute respiratory treatment that prevents mechanical ventilation while patients are awake and breathing spontaneously.
Based on sub-dynamic technology, the ART system oxygenates 1 liter of blood in a minute, within which the patient’s oxygen saturation is boosted to a safe level of 95% or higher.
The affordability and simplicity of ART’s respiratory treatment caters to millions of people worldwide who currently do not have access to ICUs. The respiratory support device is marketed to patient wards, emergency rooms, and small urban and rural hospitals.
Redefining Artificial Respiration to impact millions of lives
We are a specialty medical device company developing proprietary respiratory support technology designed to prevent the need for mechanical ventilation which is the current standard of care.
meet our team
Co-Founder, President, and CFO
Joe has executed M&As and strategic joint ventures, and holds deep experience in manufacturing and setting up operations to support high-growth delivery.
Co-Founder and CEO
Dagi is a serial entrepreneur and investor with multi-industry experience in growing companies from concept to market penetration and sales.
Prof. Benad Goldwasser
Benad is a Urologic Surgeon, inventor, entrepreneur, and venture capital investor with vast experience in leading high-growth, publicly-traded medical companies.
Udi Nussinovitch, MD-PhD
Co-Founder and Chief Scientific Officer
Udi is a board-certified Cardiologist, ICU Physician, and Cardiology Researcher, as well as a senior hyperbaric and diving physician.